Oct 31, 2017 4:48pm EDT Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECH™ Delivery of THC, NSAIDs, Nicotine and Vitamins.
Aug 31, 2017 7:55am EDT University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria's TurboCBD(TM)
Aug 10, 2017 9:00am EDT CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress
May 30, 2017 7:50am EDT Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea